Abstract: Disclosed is a method of treating an individual or animal with osteoarthritis. The method comprises administering to the individual or animal a therapeutically effective amount of a protein tyrosine kinase inhibitor.
Type:
Application
Filed:
September 23, 2002
Publication date:
March 27, 2003
Applicant:
The Osteoarthritis Sciences, Inc. Liquidating Trust
Inventors:
Thomas R. Sharpe, George W. Vasios, R. Nelson Campbell
Abstract: Applicants' invention discloses therapeutic compositions and methods for treating articular cartilage breakdown associated with osteoarthritis and rheumatoid arthritis. The compositions comprise a therapeutically effective amount of IL-4 to reduce or inhibit breakdown of articular cartilage, optionally in the presence of a pharmaceutically acceptable carrier or excipient. Methods for treating articular cartilage breakdown comprise administering a therapeutically effective amount of IL-4 to reduce or inhibit breakdown of articular cartilage, optionally in the presence of a pharmaceutically acceptable carrier to a subject in need of such treatment. The invention also relates to compositions and methods for treating tumor metastases, periodontal disease, emphysema and osteoporosis.
Type:
Grant
Filed:
May 12, 1994
Date of Patent:
October 21, 1997
Assignee:
Osteoarthritis Science, Inc.
Inventors:
Li-an Yeh, Andrew J. Augustine, Adrian Sheldon
Abstract: The present invention relates to a bile acid derivative, which comprises a bile acid derivatized at the carboxyl group with a hydroxamic acid or hydroxamate ester. The carboxyl group in the bile acid compound can also be derivatized with an amino acid or oligopeptide, whose C-terminus is derivatized with a hydroxamic acid or a hydroxamate ester. The present invention also relates to a method of use of a bile acid or a bile acid derivative to inhibit a metalloproteinase enzyme, comprising contacting a metalloproteinase with an effective amount of a bile acid or bile acid derivative. In another embodiment, the present invention further relates to a method of use of a bile acid or bile acid derivative to therapeutically treat a disease, which is ameliorated by inhibiting a metalloproteinase enzyme. In this method, a therapeutically effective amount of a bile acid, a bile acid derivative or physiologically acceptable salts thereof, is administered to a human or other mammal.
Type:
Grant
Filed:
April 25, 1995
Date of Patent:
July 8, 1997
Assignee:
OsteoArthritis Sciences, Inc.
Inventors:
Alan R. Jacobson, Douglas G. Gabler, Jozef Oleksyszyn